Summary.-The level of peripheral blood platelets was determined after i.v. injection of Corynebacterium parvum in normal C57BL mice and in those bearing the Lewis lung carcinoma.
IN THIS investigation, 2 strains of formalin-killed C. parvum were used: an active strain (CN 6134) which causes hepatosplenomegaly and inhibits tumour growth, and an inactive one (CN 5888) which does not have these effects (Adlam and Scott, 1973; Bomford and Olivotto, 1975) .
In rodents, systemic administration of active C. parrurn inhibits the development of tumour nodules in the lungs, arising either from i.v. injection of tumour cells (Milas and Mujagic, 1972; Bomford and Olivotto, 1974) or as spontaneous metastases from a tumour implant (Proctor, Rudenstam and Alexander, 1973: Sadler and Castro, 1976) . The protection afforded by this vaccine has generally been attributed to its stimulatory effect on the reticulo-endothelial system (Halpern et al., 1966 : Scott, 1974 ).
Recently we reported another effect of C. parrurn which may influence metastasis (Lampert et al., 1977) : a prolonged intravascular coagulation reaction occurs after i.v. C. parvum, resulting in thrombi in hepatic, splenic and pulmonary vessels. This thrombosis is mirrored by a fall in platelet counts. Preliminary investigations (Mitcheson and Castro, unpublished) suggest that a similar phenomenon occurs in man. A decrease in platelets and an increase in fibrin degradation products have been observed in patients given i.v. C. parvum. We now wish to report the effects of systemic C. parvrum on platelet levels in normal and tumour-bearing mice. (Sugiura and Stock, 1955) . Macroscopic surface lung metastases were counted 21 days after tumour implantation, after staining the lungs by inflation with a dilute solution of Indian ink and fixation in Fekete's solution (Wexler, 1966) . The numbers of mnetastases in the different experimental groups were compared by Student's t test.
C. pairvum. A formalin-killed suspension of active strain (Wellcome, CN 6134, batch BA 3935/A, 7 mg dry weight/ml) or inactive strain (Wellcome, CN 5888/C, (CA 500), 7 mg dry weight/ml) was injected i.v. at a dose of 0-466 mg in 0-2 ml normal saline. Control mice received an equivalent volume of saline.
Heparin. Heparin (Paines and Byrne Ltd, Batch 633010 (Mucous) B.P., preservative free) was given as 100 u i.v. at the same time as C. parvum and subsequently as 100 u s.c. 3 x Neekly.
Platelet count. Groups of 4 mice were given i.v. C. parvitum or saline, and blood was sampled at intervals after injection. Bleeding was induced from the retro-orbital plexus using a heparinised capillary tube (Hawksley, England) and a 0 02 ml sample of the effusing blood was immediately collected into a heparinised w%ihite-backed micro-pipette.
The sample was diluted in 2 ml of 1% ammonium oxalate in a plastic microcapped tube and was mechanically shaken for 3 to 5 nin. A Neubauer counting chamber was filled with the diluted sample and left for 15-20 min in a moist container in order to allow the platelets to settle. Platelets were then counted under phase, using a x 10 objective and the mean total count (± s.e.) was estimated (Miale, 1962) .
RESULTS
Within 10-20 min of injection of active-or inactive-strain C. parvum, the mice showed signs of shock, exemplified by erection of hair, respiratory distress and a "coldness to the touch". This syndrome disappeared after about 2 h.
The long-term effect of active-strain C. parvurn on platelet numbers in normal mice is shown in Fig. 1 . There was an Fig. 2 . The count in control animals was higher than in the previous experiment (Fig. 1) (Fig. 3) .
The effects of active-strain C. parvum on platelet numbers in normal mice and in those bearing the Lewis tumour were compared (Fig. 4) . Platelet levels in tumour-bearing mice were similar to those in normal animals until 13 days after tumour inoculation. Subsequently, the number of platelets fell in tumour bearers to 60%, by Day 17, of that in control mice. When C. parvum was given at the same time as tumour inoculation, the level of platelets in tumour-bearing mice was reduced and essentially similar to that in normal animals given vaccine.
A study was made of the effect of these two vaccines on spontaneous pulmonary metastases from the Lewis tumour. The results are shown in the Table. Activestrain C. parvum significantly reduced metastases (P < 0.01) whereas inactive strain had no significant effect. (Tait and Elvidge, 1926) . This is a reflection of platelets aggregating with the injected antigen (Brown and Lachman, 1973 ) . Antibody and complement may be involved in this process (Henson, 1970) .
The level of platelets returned to normal by 8 h after injection of active-strain C. parvum, whereas normal platelet values were not regained until -, 3 days after the inactive strain. Tait and Elvidge (1926) reported that injections of large amounts of particulate matter cause a greater decrease in platelet levels and a slower recovery to normal values than injections of small amounts. On a weight basis, similar quantities of the two vaccines were injected and, therefore, our results suggest that the inactive strain of C. parvum causes a greater degree of platelet aggregation than the active strain.
Only the active strain caused a second and prolonged thrombocytopenia from -16 h to 21 days after its injection. This thrombocytopenia was probably, to some extent, due to pooling of platelets in the spleen, which is enlarged after active-strain C. parvum (Adlam and Scott, 1973) . Additionally, the reduction in platelet numbers may be caused by the intravascular coagulation which occurs after i.v. injection of the active- (Lampert et al., 1977) buit not the inactive-strain C. parvrum (own unpublished work). A similar reduction of platelets has been reported during endotoxin-induced disseminated intravascular coagulation (DIC) Brown and Lachman, 1973; Beller, 1969) . Heparin is used clinically to treat DIC, and it has been reported to prevent thrombosis and to restore the level of platelets (Merskey et al., 1964; Lasch, 1969) . We therefore investigated the effect of heparin on platelet levels in C. parvum-treated mice. Up to 7 days after injection of vaccine, the number of platelets in mice given C. parvum and heparin was decreased and not significantly different from that in animals given C. parvurn alone. This suggests either that intravascular coagulation is not important in the thrombocytopenia or that an inadequate dosage of heparin was used (Good and Thomas, 1953 ). However, the platelet level at 10 days after injection was significantly higher than that in mice treated with C. parvum alone. This suggests that the thrombocytopenia which occurs after active-strain C. parvum is due, at least in part, to intravascular coagulation. It seems unlikely that C. parvum-induced thrombocytopenia is due to impairment of platelet production, as increased numbers of megakaryocytes are observed in the spleens of mice after injection of the active strain (Lampert et al., 1977) .
The level of platelets in mice bearing the Lewis tumour was similar to that in control animals up to 13 days after tumour inoculation. Subsequently, the number of platelets was reduced in tumour bearers. A similar effect has recently been reported by Poggi et al. (1977) who suggested that this phenomenon was due to an impaired production of platelets. Active-strain C. parvum caused a reduction in platelet levels in tumour-beariing mice similar to that in control animals.
The active strain of C. (Jones, Wallace and Fraser, 1971; Chew and Wallace, 1976) . Gasic et al. (1973 Gasic et al. ( , 1976 have reported that several mouse tumours cause platelet aggregation in vitro and that tumours with this capacity produce more metastases. However, there is some contrary evidence which suggests that integrity of platelet function is not a prerequisite for metastasis formation (Hagmar, 1970; Hilgard, Heller and Schmidt, 1976) . These experiments do not prove that the thrombocytopenia which occurs after active C. parvurn is responsible for the vaccine's antimetastatic effects. However, it may be a contributary factor, and we feel that this effect should be taken into account in studies on the antimetastatic action of this vaccine.
